Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.22 USD | +1.10% | +2.66% | -34.36% |
May. 29 | BofA Securities Adjusts Crane Price Target to $165 From $140, Maintains Buy Rating | MT |
May. 27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
Evolution of the average Target Price on Crane NXT
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Crane NXT
BofA Securities | |
UBS | |
Stifel Nicolaus | |
Deutsche Bank Securities | |
Vertical Research | |
DA Davidson | |
Morningstar |
EPS Revisions
- Stock Market
- Equities
- CR Stock
- CXT Stock
- Consensus Crane NXT